InGeNA has been named a finalist in the Health Industry Hub Catalysts for Change Awards 2026, in the NGO of the Year category. The awards celebrate the people and organisations working to reimagine healthcare across the sector. We are grateful to be recognised among...
Tuesday 6 October 2026 | 9.00 am to 10.30am AEDT | Online Australia is at a pivotal point in genomics and precision health — and the window to shape what comes next is open now. The forthcoming national health genomics policy framework and the Australian...
InGeNA welcomes our new member Bupa InGeNA is delighted to welcome Bupa as our newest member. Bupa is committed to making genomics a trusted, accessible, and everyday part of healthcare; delivering personalised health plans that measurably improve preventative care...
Turning clinical readiness into routine patient accessReflections from the Private Cancer Physicians of Australia Cancer Summit 2026 Private cancer physicians already see precision oncology as contemporary care. Systemic HTA reform is critical for Australia’s...
Australia is entering an important new phase for genomics and precision medicine, with growing momentum to move from research and individual programs towards clinical implementation and mainstream healthcare. InGeNA is delighted to host Dame Professor Sue Hill, Chief...
Professor Joanne Ngeow shared Singapore’s experience in building population genomics evidence and translating it into cancer prevention, clinical services and national reimbursement. Singapore’s National Precision Medicine Program began by sequencing 10,000 people,...
